NCT07537647

Brief Summary

Patients undergoing lumbar spinal stabilization surgery may experience severe postoperative pain lasting at least three days. Analgesia after lumbar stabilization surgery is beneficial for early recovery and is therefore necessary. However, traditional opioid-based analgesic techniques are associated with many undesirable effects, including nausea, vomiting, itching, and sedation. Inadequate postoperative pain control also has numerous adverse effects on physiological systems such as the cardiovascular, pulmonary, gastrointestinal, immunological, renal, and hematological systems. Furthermore, inadequate postoperative pain control increases hospital stay, mortality and morbidity, prolongs patient ambulation time, increases patient costs, reduces patient satisfaction, and can lead to chronic postoperative pain. Nonsteroidal anti-inflammatory drugs (NSAIDs), opioid analgesics, and local anesthetics are frequently preferred options for providing postoperative analgesia. In cases where these agents are insufficient to prevent pain, regional techniques are often preferred to reduce the need for opioids. Erector spina plane block (ESPB), a component of multimodal analgesia and one of the regional techniques, was first used by Forero et al. for analgesic purposes in thoracic neuropathic pain and subsequently gained popularity. While ESPB is frequently performed at the thoracic level, its use continues to increase today.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

April 6, 2026

Last Update Submit

April 16, 2026

Conditions

Keywords

ESPBspine surgerypostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • POSTOPERATIVE PAIN SCORES

    Pain will be assessed using the Numerical rating scale (NRS) score at postoperatively.

    The Numerical rating scale (NRS) score will be applied at 0, 2, 4, 6, 12, and 24 hours postoperatively.Numerical rating scale (NRS), 0 to 10. Zero indicates the absence of pain, while ten indicates severe pain.

Secondary Outcomes (1)

  • Evaluation of postoperative analgesic consumption and hospital stay duration.

    Postoperative 24-hour period

Study Arms (1)

ESPB GROUP

EXPERIMENTAL

Under ultrasound guidance, bilateral erector spinae plane block will be performed on the ESPB group one level above the appropriate area for pediatric tethered cord surgery using the anesthetic drug bupivacaine.

Device: UNDER ULTRASOUND GUİDANCE ESPB BLOCKProcedure: PROCEDURE/SURGERY: ERECTOR SPİNAE (ESP) BLOCK WİTH BUPİVACAİNE

Interventions

In the ESP Block group, with the patient in the prone position, the research anesthesia team will insert a block needle through the skin one level above the surgical level using a linear probe guided by USG. The needle will pass through the trapezius and erector spinae muscles, and upon reaching the transverse process (approximately 2-3 cm deep), a test dose of 0.5-1 mL of 0.9% NaCl will be applied between the erector spinae fascia and the vertebral transverse process to confirm needle placement. After confirmation of fascial opening, a local anesthetic volume of 2 mL per vertebral pressure will be calculated, not exceeding a maximum dose of 2 mg/kg of 0.5% bupivacaine. This total volume will be diluted by half with 0.9% NaCl solution to prepare a 0.25% bupivacaine concentration. The calculated local anesthetic solution will be applied to the erector spinae region for ESPB. The same procedures will be performed on the opposite side.

Also known as: ESPB BLOCK
ESPB GROUP

For the ESP Block group, under USG guidance with the patient in prone position, a linear probe will be placed in the parasagittal plane one level above the operative level, and after visualizing the transverse process with an in-plane approach, a 50 mm long block needle will be inserted through the skin. A test dose of 0.5-1 mL of 0.9% NaCl will be administered between the erector spinae fascia and the transverse process of the vertebra to confirm needle placement. After confirming that the fascia has opened, a local anesthetic volume of 2 mL per vertebral pressure will be calculated, not exceeding a maximum dose of 2 mg/kg of 0.5% bupivacaine. This total volume will be diluted halfway with 0.9% NaCl solution to prepare a 0.25% bupivacaine concentration. The calculated local anesthetic solution will be administered to the erector spinae area, and ESPB will be performed. The same procedures will be performed on the opposite side.

Also known as: PLANE BLOCKS
ESPB GROUP

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who volunteer to participate in the study
  • Patients aged 18-65 years
  • Patients with ASA (American Society of Anesthesiologists) physical status I, II, and III
  • Patients who will undergo elective lumbar stabilization surgery

You may not qualify if:

  • Patients who do not consent to participate in the study
  • Patients with ASA physical status IV and V
  • Patients using anticoagulant medications
  • Patients with allergy to local anesthetic drugs
  • Patients undergoing lumbar stabilization surgery at level three or higher
  • Patients with a history of gastrointestinal bleeding
  • Patients with a history of psychiatric illness (Major Depression, Schizophrenia, Bipolar Affective Disorder)
  • Patients with narcotic drug and/or alcohol dependence
  • Patients with a history of central and/or peripheral neurological disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa yüksek ihtisas eğitim ve araştırma hastanesi BURSA, Bursa, Türkiye, BURSA, Bursa 16310

Bursa, Bursa, 16310, Turkey (Türkiye)

Location

Related Publications (1)

  • Stewart JW, Dickson D, Van Hal M, Aryeetey L, Sunna M, Schulz C, Alexander JC, Gasanova I, Joshi GP. Ultrasound-guided erector spinae plane blocks for pain management after open lumbar laminectomy. Eur Spine J. 2024 Mar;33(3):949-955. doi: 10.1007/s00586-023-07881-4. Epub 2023 Aug 12.

MeSH Terms

Interventions

ParapsychologyDental OcclusionBupivacaine

Intervention Hierarchy (Ancestors)

Behavioral SciencesBehavioral Disciplines and ActivitiesDentistryDental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSOCIATE PROFESSOR

Study Record Dates

First Submitted

April 6, 2026

First Posted

April 17, 2026

Study Start

September 1, 2024

Primary Completion

April 1, 2025

Study Completion

May 1, 2025

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

The study protocol and results can be shared.

Locations